(Q24242532)

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

Clinical trials update from the Heart Failure Society of America: EMOTE, HERB-CHF, BEST genetic sub-study and RHYTHM-ICD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

Different standards for reporting ADRs to herbal remedies and conventional OTC medicines: face-to-face interviews with 515 users of herbal remedies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

Diagnosis and management of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

The existence of publication bias and risk factors for its occurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

Publication bias in clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

Language bias in randomised controlled trials published in English and German.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

Bias in location and selection of studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

Alternative therapy bias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

Guidelines for the diagnosis and treatment of chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

Diuretics for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

Digitalis for treatment of heart failure in patients in sinus rhythm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

Incidence of hospitalization for digitalis toxicity among elderly Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

Drug treatment in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

Review of the usefulness of contacting other experts when conducting a literature search for systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

ABC of heart failure. Acute and chronic management strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

Crataegus extract blocks potassium currents in guinea pig ventricular cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

What is the ideal study design for evaluation of treatment for heart failure? Insights from trials assessing the effect of ACE inhibitors on exercise capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

Bias against European journals in medical publication Databases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

Location bias in controlled clinical trials of complementary/alternative therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

Beta-blockers for congestive heart failure: what is the current consensus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

High-dose Crataegus extract WS 1442 in the treatment of NYHA stage II heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

7 January 2021

Variance imputation for overviews of clinical trials with continuous response

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

7 January 2021

Efficacy of the Hawthorn (Crataegus) preparation LI 132 in 78 patients with chronic congestive heart failure defined as NYHA functional class II

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

7 January 2021

Phytotherapy in heart failure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

7 January 2021

Survival and prognosis: investigation of Crataegus extract WS 1442 in congestive heart failure (SPICE)--rationale, study design and study protocol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

7 January 2021

Efficacy and safety of crataegus extract WS 1442 in comparison with placebo in patients with chronic stable New York Heart Association class-III heart failure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

7 January 2021

Clinical efficacy of crataegus extract WS 1442 in congestive heart failure NYHA class II

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

7 January 2021

A randomised double blind placebo controlled clinical trial of a standardised extract of fresh Crataegus berries (Crataegisan) in the treatment of patients with congestive heart failure NYHA II

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

7 January 2021

Clinical benefit of angiotensin-converting enzyme inhibitors in chronic heart failure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

7 January 2021

Crataegus special extract WS 1442 increases force of contraction in human myocardium cAMP-independently

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

7 January 2021

Herbs and dietary supplements in the prevention and treatment of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

7 January 2021

Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

7 January 2021

Exercise testing in heart failure. A critical review

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005312.PUB2

7 January 2021

10.1002/14651858.CD005312.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

18254076

1 reference

Consolidated OpenCitations Corpus – April 2017